SARS-CoV-2 is an enveloped virus responsible for the COVID-19 pandemic. Despite recent
advances in the structural elucidation of SARS-CoV-2 proteins, the detailed architecture of …

The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
led to a renewed interest in studying the role of the spike S glycoprotein in regulating …

Neutralizing antibodies and fusion inhibitory peptides have the potential required to combat
the global pandemic caused by SARS-CoV-2 and its variants. However, the lack of oral …

The N-terminal fusion peptide (residues 770–788) of an S2 glycoprotein of the severe acute
respiratory syndrome coronavirus (SARS-CoV), exposed upon receptor binding, is crucial …

The magnified infectious power of the SARS‐CoV‐2 virus compared to its precursor SARS‐
CoV is intimately linked to an enhanced ability in the mutated virus to find available …

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
introduced a relatively large number of mutations, including three mutations in the highly …

The emergence of SARS-CoV-2 Omicron and other variants of concern (VOCs) has brought
huge challenges to control the COVID-19 pandemic, calling for urgent development of …

SARS-CoV-2 spike proteins are responsible for the membrane fusion event, which allows
the virus to enter the host cell and cause infection. This process starts with the binding of the …

The virus life cycle depends on host-virus protein-protein interactions, which often involve a
disordered protein region binding to a folded protein domain. Here, we used proteomic …

The global pandemic of Coronavirus Disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to the death of more than …